1-(1,3-benzodioxol-5-yl)propan-2-amine;[2-(1,3-benzodioxol-5-yl)-1-methyl-ethyl]amine;4764-17-4;PDSP1_001410;DivK1c_000964;1-(1,3-benzodioxol-5-yl)propan-2-amine;KBio1_000964;(+-)-alpha-Methyl-1,3-benzodioxole-5-ethanamine;(+-)-alpha-Methyl-3,4-(methylenedioxy)phenethylamine;(+-)-beta-3,4-Methylenedioxyamphetamine;1,3-Benzodioxole-5-ethanamine, alpha-methyl-, (+-)- (9CI);PHENETHYLAMINE, alpha-METHYL-3,4-(METHYLENEDIOXY)-, (+-)-;Tenamfetamina [Spanish];Tenamfetamine [INN];Tenamfetaminum [Latin];PDSP2_001394;(+/-)-3,4-(Methylenedioxy)amphetamine;(R,S)-3,4-Methylenedioxyamphetamine;1,3-benzodioxole-5-ethanamine, alpha-methyl-;1-(3,4-Methylenedioxyphenyl)-2-propylamine;3,4-(Methylenedioxy)-alpha-methylphenylethylamine;3,4-Methylenedioxyphenylisopropylamine;3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine;5-(2-Aminopropyl)-1,3-benzodioxole;DL-alpha-Methyl-3,4-(methylenedioxy)phenylethylamine;EA-1299;Love;Tenamfetamine;alpha-Methyl-3,4-methylenedioxyphenethylamine;1,3-Benzodioxole,5-ethanamine-.alpha.-methyl-(.+/-.);Phenethylamine, .alpha.-methyl-3,4-(methylenedioxy)-;IDI1_000964;NINDS_000964;1,3-Benzodioxole-5-ethanamine, alpha-methyl- (9CI);3,4-Methylenedioxy-amphetamine;3,4-Methylenedioxyamphetamine;5-19-08-00417 (Beilstein Handbook Reference);AI3-24882;ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE;BRN 0150196;DEA No. 7400;MDA (pharmaceutical);Methylenedioxyamphetamine;Phenethylamine, alpha-methyl-3,4-(methylenedioxy)-;alpha-Methyl-1,3-benzodioxole-5-ethanamine
1-(1,3-benzodioxol-5-yl)propan-2-amine